In Re Rosuvastatin Calcium Patent Litigation ( 2010 )

NOTE: This order is n0nprecede11tial. United States Court of AppeaIs for the FederaI Circuit IN RE ROSUVASTATIN CALCIUM PATENT LITIGATION ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plain,tiffs-Appellees, V. AUROBINDO PHARMA LIMITED, Defen,dan,t-Appellant, and MYLAN PHARMACEUTICALS INC., Defend0:n,t-Appellant, and APOTEX CORP., Defenclant-Appellant, and COBALT PHARMACEUTICALS INC. AND COBALT LABORATORIES INC., Defendants-Appellants, - and SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendant-Appellan,t, ASTR.AZENECA V. AUROBINDO 2 and TEVA PHARMACEUTICALS USA, INC., Defendcmt-Appellan.t, and PAR PHARMACEUTICAL, INC., Defendczn,t-Appellant, and SANDOZ, INC., Defend0:n,t. 2010-1460, -1461, -1462, -1463, -1464, -1465, -1466, -1467, -1468, -1469, -1470, -1471, -1472, -1473 Appea1s from the United States District Court for the District of De1aware in case nos. 08-MD-1949, 07-CV- 0810, 07-CV-0805, 07-CV-0809, 07-CV-0811, 07-CV-0806, 08-CV-0426, and 07 -CV-0808, Judge J0seph J. Farnan, Jr. ON MOTION ORDER Upon consideration of the motion to withdraw Rich- ard A. Kap1an and to substitute Jeffry M. Nich0Is as principal counsel for Teva Pharmaceutica1s USA, Inc., IT ls 0RDERED THAT: _ The motion is granted JefEry M. Nicho1s must promptly enter a new entry of appearance 3 UCT 1 9 2010 Date cc: Char1es E. Lipsey, Esq. Robert B. Breisblatt, Esq. Jeffrey S. Ward, Esq. SteVen A. Maddox, Esq. Wi1]iam A. Rakoczy, Esq. Dutch Chung, Esq. J ames F. Hurst, Esq. Richard A. Kap1an, Esq. Jeffry M. Nicho1s, Esq. s21 AsTRAzENEcA v. AURo1-:>.1Nno FoR THE C0URT /s/ J an Horba1y J an Horb aly C1erk F l..ED U.S. COURT BF APPEALS FOR THE FEDERAL C|RCU|T 0CT 1 8 2010 .IANHORBAL‘l CLERK